Work

Dasatinib 100 Mg Once Daily (QD) Maintains Long-Term Efficacy and Minimizes the Occurrence of Pleural Effusion: An Analysis of 24-Month Data in Patients with Resistance, Suboptimal Response, or Intolerance to Imatinib (CA180-034).

Year: 2008

Type: article

Source: Blood

DOI: 10.1182/blood.v112.11.3242.3242

Authors: Kimmo Porkka, H. Jean Khoury, Ronald Paquette, Yousif Matloub, David Liu, Ritwik Sinha, Jorge Cortes

Institutions: Emory University, Ronald Reagan UCLA Medical Center, Bristol-Myers Squibb (United States), The University of Texas MD Anderson Cancer Center

Language: English

Topic: Chronic Myeloid Leukemia Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2980953181

FWCI: 1.254

Cites:

Cited by: 6

Related to: 10